Rescue doses of crovalimab for managing breakthrough hemolysis during treatment for PNH

In this interview, Austin Kulasekararaj, MBBS, MD, MRCP, FRCPath, King's College Hospital NHS Foundation Trust, London, UK, comments on the use of rescue doses for managing breakthrough hemolysis events during crovalimab treatment in patients with paroxysmal nocturnal hemoglobinuria (PNH), highlighting the results from a study investigating this. This interview took place at the 2nd International PNH Interest Group (IPIG) Conference in Paris, France.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Видео Rescue doses of crovalimab for managing breakthrough hemolysis during treatment for PNH канала VJHemOnc – Video Journal of Hematology & HemOnc